Disruptive surgical robotic system offers less pain, faster recovery and less scarring – Surgical Techniques
Image: The Levita MARS platform is designed to make robotic surgery accessible to everyone (Photo courtesy of Levita Magnetics)
A new robotic platform is designed to provide clinical benefits such as less pain, faster recovery and less scarring for patients undergoing abdominal surgeries.
The MARS (Magnetic-Assisted Robotic Surgery) platform from Levita Magnetics (Menlo Park, CA, USA) is designed to improve the efficiency and quality of procedures in high-volume abdominal surgeries, by improving surgical access to patients and allowing a less invasive approach with fewer incisions, while allowing the surgeon full control of the platform and surgical instruments directly next to the patient. The MARS platform is intended to improve visualization, maintain surgeon control of instruments, and increase hospital efficiency with fewer support staff required to perform procedures.
With its compact footprint, the new robotic platform is designed for outpatient or same-day discharge procedures in high-volume abdominal surgeries. MARS aims to increase the volume of high-quality, efficiently performed procedures while increasing access by making robotic surgery available across the spectrum of care – from community to academic centers and improving the patient experience. The MARS platform is an experimental system. It is not available for sale in the United States and has not been cleared by the Food and Drug Administration (FDA).
“At Levita, we believe everyone deserves the benefits of MARS, offering the potential for less pain, faster recovery, and less scarring. Our platform is poised to solve the global problem of limited access to better robotic surgery,” said Dr. Alberto Rodriguez-Navarro, surgeon, founder and CEO of Levita Magnetics.